# Adjuvant Breast Cancer Study of the Netherlands Working Party for Autotransplantation in Solid Tumors

> **NCT00851110** · PHASE2 · TERMINATED · sponsor: **University Medical Center Groningen** · enrollment: 50 (estimated)

## Conditions studied

- High-Risk Breast Cancer

## Interventions

- **PROCEDURE:** stem cell reinfusion
- **DRUG:** Chemotherapy

## Key facts

- **NCT ID:** NCT00851110
- **Lead sponsor:** University Medical Center Groningen
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2004-10
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2009-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00851110

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00851110, "Adjuvant Breast Cancer Study of the Netherlands Working Party for Autotransplantation in Solid Tumors". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00851110. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*